+Search query
-Structure paper
Title | Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy |
---|---|
Journal, issue, pages | To Be Published |
Publish date | Feb 21, 2025 (structure data deposition date) |
![]() | Maso L / Mosure SA / Rodriguez-Aponte SA / Pizzo A / Mensah DN / Southard M / Sze S / Vash B / Hattori T / Rajak E ...Maso L / Mosure SA / Rodriguez-Aponte SA / Pizzo A / Mensah DN / Southard M / Sze S / Vash B / Hattori T / Rajak E / Koide A / Neel BG / Koide S / Liu W / Toenjes ST / DaSilva-Jardine P / Chopra R / Rader C / Stopfer LE |
![]() | Search PubMed |
Methods | EM (single particle) |
Resolution | 2.58 - 3.23 Å |
Structure data | EMDB-49361, PDB-9nfb: EMDB-49362, PDB-9nfc: |
Chemicals | ![]() PDB-1awr: |
Source |
|
![]() | PROTEIN BINDING / Antibody / Cancer-neoantigen / complex |